EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Approach to Develop New and Potent Inhibitors for the Simultaneous Inhibition of Protease and Helicase Activities of HCV NS3/4A Protease: A Computational Approach

Muhammad Riaz, Ashfaq Ur Rehman iD, Muhammad Waqas iD, Asaad Khalid iD, Ashraf N Abdalla iD, Arif Mahmood iD, Junjian Hu, Abdul Wadood iD

Molecules · 2023

DOI: 10.3390/molecules28031300 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Muhammad Riaz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Computational Medicinal Chemistry Laboratory, Department of Biochemistry, Abdul Wali Khan University Mardan, Mardan 23200, Pakistan. Hauptthemen laut MEDLINE: Molecular Dynamics Simulation, Hepatitis C. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research at Umm Al-Qura University, HEC of Pakistan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infection of hepatitis C (HCV) is a major threat to human health throughout the world. The current therapy program suffers from restricted efficiency and low tolerance, and there is serious demand frr novel medication. NS3/4A protease is observed to be very effective target for the treatment of HCV. A data set of the already reported HCV NS3/4A protease inhibitors was first docked into the NS3/4A protease (PDB ID: 4A92A) active sites of both protease and helicase sites for calculating the docking score, binding affinity, binding mode, and solvation energy. Then the data set of these reported inhibitors was used in a computer-based program “RECAP Analyses” implemented in MOE to fragment every molecule in the subset according to simple retrosynthetic analysis rules. The RECAP analysis fragments were then used in another computer-based program “RECAP Synthesis” to randomly recombine and generate synthetically reasonable novel chemical structures. The novel chemical structures thus produced were then docked against HCV NS3/4A. After a thorough validation of all undertaken steps, based on Lipinski’s rule of five, docking score, binding affinity, solvation energy, and Van der Waal’s interactions with HCV NS3/4A, 12 novel chemical structures were identified as inhibitors of HCV NS3/4A. The novel structures thus designed are hoped to play a key role in the development of new effective inhibitors of HCV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Dynamics SimulationHepatitis CHumansEndopeptidasesHepacivirusCatalytic DomainViral Nonstructural ProteinsProtease InhibitorsAntiviral Agents

Stichwörter der Autor:innen

HCV NS3/4A proteaseRECAP analysesRECAP synthesisinhibitorsmolecular docking

Substanzen

EndopeptidasesViral Nonstructural ProteinsProtease InhibitorsAntiviral Agents

Autor:innen und Institutionen

  • Computational Medicinal Chemistry Laboratory, Department of Biochemistry, Abdul Wali Khan University Mardan, Mardan 23200, Pakistan.
  • School of Biological Science, University of California, Irvine, CA 92697, USA.
  • Natural and Medical Sciences Research Center, University of Nizwa, Birkat Al Mauz, P.O. Box 33, Nizwa 616, Oman.
  • Substance Abuse and Toxicology Research Center, Jazan University, P.O. Box 114, Jazan 45142, Saudi Arabia.
  • Medicinal and Aromatic Plants and Traditional Medicine Research Institute, National Center for Research, Khartoum P.O. Box 2404, Sudan.
  • Department of Pharmacology and Toxicology, College of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia.

ORCID-Profile: Ashfaq Ur Rehman, Muhammad Waqas, Asaad Khalid, Ashraf N Abdalla, Arif Mahmood, Abdul Wadood

Förderung

  • Deanship of Scientific Research at Umm Al-Qura University
  • HEC of Pakistan

Zitieren

APA

Riaz, M., Rehman, A. U., Waqas, M., Khalid, A., Abdalla, A. N., Mahmood, A., Hu, J., & Wadood, A. (2023). A Novel Approach to Develop New and Potent Inhibitors for the Simultaneous Inhibition of Protease and Helicase Activities of HCV NS3/4A Protease: A Computational Approach. Molecules. https://doi.org/10.3390/molecules28031300

Vancouver

Riaz M, Rehman AU, Waqas M, Khalid A, Abdalla AN, Mahmood A, et al. A Novel Approach to Develop New and Potent Inhibitors for the Simultaneous Inhibition of Protease and Helicase Activities of HCV NS3/4A Protease: A Computational Approach. Molecules. 2023. doi:10.3390/molecules28031300

BibTeX
@article{Riaz2023,
  author = {Riaz, Muhammad and Rehman, Ashfaq Ur and Waqas, Muhammad and Khalid, Asaad and Abdalla, Ashraf N and Mahmood, Arif and Hu, Junjian and Wadood, Abdul},
  title = {A Novel Approach to Develop New and Potent Inhibitors for the Simultaneous Inhibition of Protease and Helicase Activities of HCV NS3/4A Protease: A Computational Approach},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28031300}
}
Kostenlos starten →